Business Description
![Crinetics Pharmaceuticals Inc Crinetics Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000BH66.png?14)
Crinetics Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US22663K1079
Description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.16 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.21 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 20.15 | |||||
Beneish M-Score | 4.03 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -16.2 | |||||
3-Year EPS without NRI Growth Rate | -15.1 | |||||
3-Year FCF Growth Rate | -13 | |||||
3-Year Book Growth Rate | 15.6 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.85 | |||||
9-Day RSI | 49.18 | |||||
14-Day RSI | 48.28 | |||||
6-1 Month Momentum % | 45.57 | |||||
12-1 Month Momentum % | 155.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 17.72 | |||||
Quick Ratio | 17.72 | |||||
Cash Ratio | 17.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.4 | |||||
Shareholder Yield % | -21.93 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -12571.38 | |||||
Net Margin % | -11928.27 | |||||
FCF Margin % | -9341.1 | |||||
ROE % | -47.16 | |||||
ROA % | -41.13 | |||||
ROIC % | -429.16 | |||||
ROC (Joel Greenblatt) % | -681.86 | |||||
ROCE % | -46.52 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1382.12 | |||||
PB Ratio | 4.09 | |||||
Price-to-Tangible-Book | 4.09 | |||||
EV-to-EBIT | -11.07 | |||||
EV-to-EBITDA | -11.13 | |||||
EV-to-Revenue | 1392.26 | |||||
EV-to-Forward-Revenue | 1469.69 | |||||
EV-to-FCF | -14.9 | |||||
Price-to-Net-Current-Asset-Value | 4.4 | |||||
Price-to-Net-Cash | 4.49 | |||||
Earnings Yield (Greenblatt) % | -9.03 | |||||
FCF Yield % | -5.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Crinetics Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.825 | ||
EPS (TTM) (€) | -3.495 | ||
Beta | 0.25 | ||
Volatility % | 74.33 | ||
14-Day RSI | 48.28 | ||
14-Day ATR (€) | 1.077222 | ||
20-Day SMA (€) | 42.04 | ||
12-1 Month Momentum % | 155.56 | ||
52-Week Range (€) | 14.6 - 47.6 | ||
Shares Outstanding (Mil) | 78.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Crinetics Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Crinetics Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Crinetics Pharmaceuticals Inc Frequently Asked Questions
What is Crinetics Pharmaceuticals Inc(STU:6Z4)'s stock price today?
The current price of STU:6Z4 is €42.00. The 52 week high of STU:6Z4 is €47.60 and 52 week low is €14.60.
When is next earnings date of Crinetics Pharmaceuticals Inc(STU:6Z4)?
The next earnings date of Crinetics Pharmaceuticals Inc(STU:6Z4) is 2024-08-08 Est..
Does Crinetics Pharmaceuticals Inc(STU:6Z4) pay dividends? If so, how much?
Crinetics Pharmaceuticals Inc(STU:6Z4) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |